April 04, 2021
1 min read
FX Solutions announced in a press release that it received FDA clearance for its Easytech Stemless Anatomic shoulder prosthesis, intended to treat painful and disabled shoulder joints.
According to the release, the device is the only stemless shoulder prosthesis with primary peripheral fixation on the market.
“This is a very exciting addition to our comprehensive portfolio and will allow us to compete in the stemless market with a tremendous prosthesis that, with its primary peripheral fixation, should give us a competitive advantage and potentially improve patient outcomes with a bone sparing device,” Baptiste Martin, CEO of FX Shoulder, said in the release.
According to the release, the Easytech Anchor base allows the device to fit inside the cortical bone, where bone quality is optimal for fixation.
“Since its launch in Europe, the Easytech Stemless Anatomic has become the primary choice of surgeons for their anatomic total shoulder replacements with demonstrated excellent clinical success,” according to the release.